Character
The Story of Belambre
Belambre is a modern synthetic amber-woody aromachemical developed by IFF as a non-steroidal alternative to traditional amber materials. With CAS 188199-50-0, it delivers a spicy woody character balanced by warm amber tonalities, offering perfumers a clean, sustainable option for creating depth and radiance without relying on animal-derived ambergris.
Heritage
The development of Belambre emerged from the fragrance industry's ongoing quest to replicate the elusive warmth of ambergris without relying on animal-derived materials. For centuries, perfumers coveted ambergris, a substance produced in the digestive systems of sperm whales and found floating on ocean surfaces. By the late twentieth century, growing ethical concerns and supply instability drove intensive research into synthetic alternatives. Belambre joined a new generation of non-steroidal amber molecules developed during this period, alongside materials like Karanal, Spirambrene, and Ysamber K.
IFF introduced Belambre as part of their expanding palette of modern amber materials, positioning it as a cleaner, more sustainable option that avoids the complex supply chains and ethical questions surrounding natural ambergris. The molecule quickly gained traction among contemporary perfumers seeking to create warm, woody compositions with a contemporary edge. Its inclusion in 27 87 Genetic Bliss demonstrated its ability to anchor modern niche fragrances with a distinctive character that bridges traditional amber warmth and cutting-edge synthetic innovation. Today, Belambre represents the ongoing evolution of amber in perfumery, a testament to how molecular innovation can honor classical scent profiles while embracing ethical and sustainable practices.
At a Glance
1
Feature this note
Not Classified
Olfactive group
Synthetic
Lab-crafted
Ingredient Details
Chemical synthesis
Synthetic molecule (C16H28O2)
Did You Know
"Belambre belongs to a family of modern amber molecules developed as sustainable alternatives to ambergris, alongside Karanal, Spirambrene, and Ysamber K."







